Tilray Brands (TLRY) Goodwill & Intangibles (2017 - 2026)
Tilray Brands (TLRY) posted Goodwill & Intangibles of $775.7 million for Q1 2026, little changed on a QoQ basis from $774.1 million in Q4 2025, and down 50.59% year-over-year from $1.6 billion in Q1 2025.
Tilray Brands (TLRY) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Tilray Brands' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $775.7 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 50.59% year-over-year to $775.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $775.7 million (down 50.59% YoY) and the FY2025 annual result came in at $773.8 million, down 79.41% from the prior year.
- Goodwill & Intangibles was $775.7 million for Q1 2026 at Tilray Brands, roughly flat from $774.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $4.2 billion in Q3 2022 and bottomed at $104.1 million in Q1 2022.
- A 5-year average of $2.5 billion and a median of $3.0 billion in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles jumped 3345.95% — and 2025, when it tumbled 79.41%.
- Tilray Brands' Goodwill & Intangibles stood at $3.8 billion in 2022, then decreased by 22.76% to $3.0 billion in 2023, then decreased by 3.24% to $2.9 billion in 2024, then tumbled by 73.0% to $774.1 million in 2025, then rose by 0.21% to $775.7 million in 2026.
- Business Quant data shows TLRY's Goodwill & Intangibles at $775.7 million in Q1 2026, $774.1 million in Q4 2025, and $786.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 775.69 Mn |
| Nov 30, 2025 | 774.09 Mn |
| Aug 31, 2025 | 786.19 Mn |
| May 31, 2025 | 773.77 Mn |
| Feb 28, 2025 | 1.57 Bn |
| Nov 30, 2024 | 2.87 Bn |
| Aug 31, 2024 | 3.62 Bn |
| May 31, 2024 | 3.76 Bn |
| Feb 29, 2024 | 3.60 Bn |
| Nov 30, 2023 | 2.96 Bn |
| Aug 31, 2023 | 2.98 Bn |
| May 31, 2023 | 2.98 Bn |
| Feb 28, 2023 | 3.59 Bn |
| Nov 30, 2022 | 3.84 Bn |
| Aug 31, 2022 | 4.21 Bn |
| May 31, 2022 | 3.92 Bn |
| Feb 28, 2022 | 104.07 Mn |
| Nov 30, 2021 | 1.66 Bn |
| Aug 31, 2021 | 4.39 Bn |
| May 31, 2021 | 4.44 Bn |